Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,314 | 87 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Acclarent, Inc | $705.91 | 13 | $0 (2022) |
| Stryker Corporation | $289.71 | 21 | $0 (2019) |
| OptiNose US, Inc. | $235.54 | 14 | $0 (2022) |
| GlaxoSmithKline, LLC. | $183.27 | 4 | $0 (2023) |
| Intersect ENT, Inc. | $154.23 | 3 | $0 (2022) |
| Fujifilm New Development USA, Inc. | $110.46 | 1 | $0 (2018) |
| Cook Incorporated | $97.87 | 1 | $0 (2017) |
| ARBOR PHARMACEUTICALS, INC. | $96.52 | 6 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $91.94 | 4 | $0 (2023) |
| Entellus Medical, Inc. | $74.49 | 7 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $229.89 | 6 | GlaxoSmithKline, LLC. ($183.27) |
| 2022 | $441.32 | 9 | Acclarent, Inc ($351.81) |
| 2021 | $177.85 | 4 | Acclarent, Inc ($104.20) |
| 2020 | $151.09 | 9 | OptiNose US, Inc. ($123.27) |
| 2019 | $367.54 | 13 | Acclarent, Inc ($120.88) |
| 2018 | $506.55 | 31 | Stryker Corporation ($241.34) |
| 2017 | $439.55 | 15 | Acclarent, Inc ($116.96) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/06/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: IMMUNOLOGY | ||||||
| 06/02/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/16/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/28/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: IMMUNOLOGY | ||||||
| 02/03/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/01/2022 | Acclarent, Inc | RELIEVA SPINPLUS (Device) | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: Rhinology | ||||||
| 09/22/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/19/2022 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/16/2022 | Aerin Medical Inc. | — | Food and Beverage | In-kind items and services | $12.61 | General |
| 09/10/2022 | Acclarent, Inc | TruDi NAV Cable (Device) | Food and Beverage | In-kind items and services | $120.90 | General |
| Category: Rhinology Otology Laryngology Neurosurgery | ||||||
| 06/07/2022 | Acclarent, Inc | Acclarent Aera (Device) | Food and Beverage | In-kind items and services | $97.52 | General |
| Category: Rhinology Otology | ||||||
| 03/09/2022 | Intersect ENT, Inc. | SINUVA (Drug) | Food and Beverage | In-kind items and services | $31.08 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 02/16/2022 | Acclarent, Inc | — | Food and Beverage | In-kind items and services | $112.00 | General |
| 01/06/2022 | Acclarent, Inc | — | Food and Beverage | In-kind items and services | $10.35 | General |
| 12/09/2021 | Intersect ENT, Inc. | PROPEL (Device) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/17/2021 | Acclarent, Inc | Acclarent Navwire (Device) | Food and Beverage | In-kind items and services | $104.20 | General |
| Category: Rhinology | ||||||
| 06/16/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 05/07/2021 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/09/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/25/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 09/14/2020 | Smith+Nephew, Inc. | Coblator IQ (Device) | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: Spine | ||||||
| 09/04/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/10/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $7.84 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/10/2020 | OptiNose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $4.07 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 679 | 781 | $161,030 | $69,288 |
| 2022 | 16 | 2,053 | 2,834 | $670,335 | $308,078 |
| 2021 | 16 | 1,879 | 2,590 | $612,525 | $295,831 |
| 2020 | 14 | 1,563 | 2,145 | $501,630 | $222,962 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2023 | 85 | 124 | $43,400 | $19,747 | 45.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 192 | $33,600 | $17,480 | 52.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 106 | 106 | $21,200 | $7,815 | 36.9% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2023 | 53 | 63 | $15,750 | $6,348 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 90 | 96 | $14,400 | $5,737 | 39.8% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 119 | 124 | $15,540 | $4,181 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $8,700 | $3,780 | 43.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 21 | $5,250 | $2,589 | 49.3% |
| 92511 | Exam of the nose and throat using an endoscope | Office | 2023 | 14 | 14 | $2,590 | $1,389 | 53.6% |
| 92504 | Exam of ear using a microscope | Office | 2023 | 11 | 12 | $600.00 | $222.78 | 37.1% |
| 31231 | Diagnostic exam of nasal passages using an endoscope | Office | 2022 | 244 | 423 | $148,050 | $69,604 | 47.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 384 | 658 | $115,150 | $66,882 | 58.1% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Office | 2022 | 172 | 277 | $66,300 | $28,844 | 43.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 139 | 191 | $47,750 | $27,262 | 57.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 311 | 311 | $62,200 | $26,673 | 42.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 154 | 154 | $46,200 | $20,292 | 43.9% |
| 31237 | Biopsy or removal of nasal polyp or tissue using an endoscope | Office | 2022 | 17 | 47 | $38,000 | $15,337 | 40.4% |
| 69210 | Removal of impacted ear wax | Office | 2022 | 289 | 355 | $41,510 | $12,649 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 129 | 152 | $22,800 | $11,282 | 49.5% |
| 31238 | Control of bleeding of nose using an endoscope | Office | 2022 | 26 | 48 | $27,300 | $10,693 | 39.2% |
| 31525 | Diagnostic exam of voice box using an endoscope | Facility | 2022 | 36 | 39 | $24,960 | $5,379 | 21.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 40 | 41 | $10,250 | $4,681 | 45.7% |
| 91034 | Monitoring and recording of esophageal function through nasal tube | Office | 2022 | 16 | 16 | $4,800 | $2,758 | 57.5% |
| 92511 | Exam of the nose and throat using an endoscope | Office | 2022 | 15 | 25 | $4,625 | $2,617 | 56.6% |
| 31575 | Diagnostic exam of voice box using a flexible endoscope | Facility | 2022 | 32 | 34 | $7,750 | $1,775 | 22.9% |
About Dr. Alan Shikani, M.D
Dr. Alan Shikani, M.D is a Otolaryngology healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962428979.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Shikani, M.D has received a total of $2,314 in payments from pharmaceutical and medical device companies, with $229.89 received in 2023. These payments were reported across 87 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($2,314).
As a Medicare-enrolled provider, Shikani has provided services to 6,174 Medicare beneficiaries, totaling 8,350 services with total Medicare billing of $896,159. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Otolaryngology
- Location Baltimore, MD
- Active Since 07/14/2006
- Last Updated 07/15/2024
- Taxonomy Code 207Y00000X
- Entity Type Individual
- NPI Number 1962428979
Products in Payments
- ENTELLUS - XPRESS ENT DILATION SYSTEM (Device) $273.81
- Xhance (Drug) $235.54
- NUCALA (Biological) $183.27
- SINUVA (Drug) $127.08
- TruDi NAV Cable (Device) $120.90
- ACCLARENT NAVWIRE SINUS NAVIGATION GUIDEWIRE (Device) $120.88
- ACCLARENT Balloon Inflation Device (Device) $116.96
- Cook Medical Biodesign (Device) $112.27
- Acclarent Navwire (Device) $104.20
- Acclarent Aera (Device) $97.52
- Otovel (Drug) $96.52
- DUPIXENT (Biological) $91.94
- CUVITRU (Biological) $43.23
- XprESS Multi-Sinus Dilation System (Device) $37.61
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM CONSUMABLES (Device) $36.75
- Auvi-Q (Drug) $34.44
- C Topical Solution 4 CII (Drug) $33.43
- CLARIFIX (Device) $29.40
- Coblation - Turbinate Wands (Device) $28.60
- Coblator IQ (Device) $27.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Otolaryngology Doctors in Baltimore
Marc Dubin, M.d, M.D
Otolaryngology — Payments: $315,558
Andrew Lane, M.d, M.D
Otolaryngology — Payments: $40,413
Dr. Frank Lin, Md, MD
Otolaryngology — Payments: $32,430
Jean Kim, M.d, M.D
Otolaryngology — Payments: $28,813
Nicholas Rowan, M.d, M.D
Otolaryngology — Payments: $23,975
Dr. Rodney Taylor, M.d, M.D
Otolaryngology — Payments: $15,864